Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neptune Technologies & Bioressources Inc (NASDAQ:NEPT)

1.10
Delayed Data
As of Jan 17
 +0.05 / +4.76%
Today’s Change
0.86
Today|||52-Week Range
1.53
+13.17%
Year-to-Date
No recent news for Neptune Technologies & Bioressources Inc.

Today’s Trading

Previous close1.05
Today’s open1.15
Day’s range1.08 - 1.16
Volume376,202
Average volume (3 months)365,175
Market cap$85.7M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+77.35%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+29.33%
P/E ratio--
Price/Sales4.49
Price/Book2.17

Competitors

 Today’s
change
Today’s
% change
CFRXContraFect Corp-0.10-4.88%
PIRSPieris Pharmaceutica...-0.05-2.60%
ONSOncobiologics Inc+0.20+6.73%
AKTXAkari Therapeutics P...+0.54+6.95%
Data as of 01/17/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$17.3M
Annual profit (last year)-$5.7M
Net profit margin-33.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
James S. Hamilton
Chief of Operations &
Technical Services
Marie Chantal Turcotte
Corporate headquarters
Laval, Quă©bec

Forecasts


Search for Jobs